611 related articles for article (PubMed ID: 28838808)
21. Pyrimidinyl Biphenylureas Act as Allosteric Modulators to Activate Cannabinoid Receptor 1 and Initiate
Jagla CAD; Scott CE; Tang Y; Qiao C; Mateo-Semidey GE; Yudowski GA; Lu D; Kendall DA
Mol Pharmacol; 2019 Jan; 95(1):1-10. PubMed ID: 30322873
[TBL] [Abstract][Full Text] [Related]
22. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
Brents LK; Gallus-Zawada A; Radominska-Pandya A; Vasiljevik T; Prisinzano TE; Fantegrossi WE; Moran JH; Prather PL
Biochem Pharmacol; 2012 Apr; 83(7):952-61. PubMed ID: 22266354
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development.
Ford BM; Franks LN; Radominska-Pandya A; Prather PL
PLoS One; 2016; 11(12):e0167240. PubMed ID: 27936172
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
25. CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.
Baillie GL; Horswill JG; Anavi-Goffer S; Reggio PH; Bolognini D; Abood ME; McAllister S; Strange PG; Stephens GJ; Pertwee RG; Ross RA
Mol Pharmacol; 2013 Feb; 83(2):322-38. PubMed ID: 23160940
[TBL] [Abstract][Full Text] [Related]
26. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.
Rajasekaran M; Brents LK; Franks LN; Moran JH; Prather PL
Toxicol Appl Pharmacol; 2013 Jun; 269(2):100-8. PubMed ID: 23537664
[TBL] [Abstract][Full Text] [Related]
27. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
Hruba L; Ginsburg BC; McMahon LR
J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid 1 (CB
Manning JJ; Rawcliffe G; Finlay DB; Glass M
Br J Pharmacol; 2023 Feb; 180(3):369-382. PubMed ID: 36250246
[TBL] [Abstract][Full Text] [Related]
29. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
Breivogel CS; Vaghela MS
J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB
Mahardhika AB; Ressemann A; Kremers SE; Gregório Castanheira MS; Schoeder CT; Müller CE; Pillaiyar T
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200493. PubMed ID: 36437108
[TBL] [Abstract][Full Text] [Related]
31. Noribogaine is a G-protein biased κ-opioid receptor agonist.
Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
[TBL] [Abstract][Full Text] [Related]
32. Slowly Signaling G Protein-Biased CB
Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
[TBL] [Abstract][Full Text] [Related]
33. Structurally Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice.
Dunn AD; Reed B; Guariglia C; Dunn AM; Hillman JM; Kreek MJ
Int J Neuropsychopharmacol; 2018 Sep; 21(9):847-857. PubMed ID: 29635340
[TBL] [Abstract][Full Text] [Related]
34. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
Eldeeb K; Leone-Kabler S; Howlett AC
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
[TBL] [Abstract][Full Text] [Related]
35. The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brain.
Breivogel CS; Puri V; Lambert JM; Hill DK; Huffman JW; Razdan RK
J Recept Signal Transduct Res; 2013 Dec; 33(6):367-79. PubMed ID: 24094141
[TBL] [Abstract][Full Text] [Related]
36. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
37. The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor.
Leo LM; Al-Zoubi R; Hurst DP; Stephan AP; Zhao P; Tilley DG; Miess E; Schulz S; Abood ME; Reggio PH
Cannabis Cannabinoid Res; 2023 Oct; 8(5):731-748. PubMed ID: 35792570
[No Abstract] [Full Text] [Related]
38. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
39. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
[TBL] [Abstract][Full Text] [Related]
40. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
